These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15890006)

  • 1. Oxidative damage in Parkinson's disease.
    Sherer TB; Greenamyre JT
    Antioxid Redox Signal; 2005; 7(5-6):627-9. PubMed ID: 15890006
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease. Dopamine may sustain toxic protein.
    Couzin J
    Science; 2001 Nov; 294(5545):1257-8. PubMed ID: 11701896
    [No Abstract]   [Full Text] [Related]  

  • 3. Redox imbalance.
    Berg D; Youdim MB; Riederer P
    Cell Tissue Res; 2004 Oct; 318(1):201-13. PubMed ID: 15365815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquinone (coenzyme Q10) and complex I in mitochondrial oxidative disorder of Parkinson's disease.
    Ebadi M; Muralikrishnan D; Pellett LJ; Murphy T; Drees K
    Proc West Pharmacol Soc; 2000; 43():55-63. PubMed ID: 11056957
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in the mechanisms of Parkinson's disease.
    Tolleson CM; Fang JY
    Discov Med; 2013 Jan; 15(80):61-6. PubMed ID: 23375015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson's disease.
    Gu Z; Nakamura T; Yao D; Shi ZQ; Lipton SA
    Cell Death Differ; 2005 Sep; 12(9):1202-4. PubMed ID: 16094397
    [No Abstract]   [Full Text] [Related]  

  • 7. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
    Bisaglia M; Filograna R; Beltramini M; Bubacco L
    Ageing Res Rev; 2014 Jan; 13():107-14. PubMed ID: 24389159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.
    Kikuchi A; Takeda A; Onodera H; Kimpara T; Hisanaga K; Sato N; Nunomura A; Castellani RJ; Perry G; Smith MA; Itoyama Y
    Neurobiol Dis; 2002 Mar; 9(2):244-8. PubMed ID: 11895375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.
    Norris EH; Giasson BI
    Antioxid Redox Signal; 2005; 7(5-6):672-84. PubMed ID: 15890012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different patterns of oxidized lipid products in plasma and urine of dengue fever, stroke, and Parkinson's disease patients: cautions in the use of biomarkers of oxidative stress.
    Lee CY; Seet RC; Huang SH; Long LH; Halliwell B
    Antioxid Redox Signal; 2009 Mar; 11(3):407-20. PubMed ID: 18785817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?
    Michel PP; Ruberg M; Hirsch E
    Sci STKE; 2006 Apr; 2006(332):pe19. PubMed ID: 16639033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative damage and cytogenic analysis in leukocytes of Parkinson's disease patients.
    Leblhuber F; Neurauter G; Fuchs D
    Neurology; 2003 Feb; 60(4):729; author reply 729. PubMed ID: 12601131
    [No Abstract]   [Full Text] [Related]  

  • 13. Peroxiredoxin 5 links mitochondrial redox signalling with calcium dynamics: impact on Parkinson's disease.
    Davey GP; Bolaños JP
    J Neurochem; 2013 May; 125(3):332-3. PubMed ID: 23442153
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease.
    Floor E
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):709-20. PubMed ID: 10875434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What process causes nigral cell death in Parkinson's disease?
    Jenner P
    Neurol Clin; 1992 May; 10(2):387-403. PubMed ID: 1584181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?
    Andersen JK
    Novartis Found Symp; 2001; 235():11-20; discussion 20-5. PubMed ID: 11280021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1: a potential pathological factor in Parkinson's disease?--From endoplasmic reticulum stress to beyond.
    Jain A
    J Neurol Sci; 2014 Sep; 344(1-2):236-7. PubMed ID: 24998514
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial oxidative phosphorylation defects in Parkinson's disease.
    Wallace DC; Shoffner JM; Watts RL; Juncos JL; Torroni A
    Ann Neurol; 1992 Jul; 32(1):113-4. PubMed ID: 1642467
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
    Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
    Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stuck in the craw.Parkinson's proteins choke cell's recycling system.
    Leslie M
    Sci Aging Knowledge Environ; 2004 Sep; 2004(35):nf80. PubMed ID: 15342919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.